SPRY4 and breast cancer: AC026904.1, Urothelial Carcinoma‐associated 1 (UCA1), SPRY4 intronic transcript 1 (SPRY4‐IT1), microvascular invasion in hepatocellular carcinoma (MVIH), Colon Cancer Associated Transcript 2 (CCAT2), promoter of CDKN1A antisense DNA damage activated RNA (PANDAR) and zinc finger antisense 1 (ZFAS1) and H19 lncRNA, is overexpressed in 73% of breast cancer tissues compared to healthy tissues.18